Aldeyra Therapeutics, Inc. (ALDX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 66.27T | 71.78M | 77.46M | 84.56M | 92.73M | 104.07M | 116.72M | 125.65M | 140.85M | 147.81M | 147.21M | 155.48M |
| Cash & Short-Term Investments | 65T | 70.04M | 75.3M | 81.92M | 90.06M | 101.15M | 112.74M | 120.33M | 133.04M | 142.82M | 143.33M | 151.68M |
| Cash Only | 65T | 70.04M | 59.34M | 41.24M | 50.35M | 54.53M | 68.12M | 71.03M | 102.49M | 142.82M | 143.33M | 151.68M |
| Short-Term Investments | 0 | 0 | 15.96M | 40.68M | 39.71M | 46.62M | 44.62M | 49.3M | 30.55M | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 755.54K | 0 | 40M | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.27T | 1.34M | 2.16M | 1.61M | 1.77M | 2.51M | -37.17M | 4.28M | 7.68M | 4.65M | 3.27M | 2.93M |
| Total Non-Current Assets | 209.26B | 275.86K | 340.98K | 404.66K | 466.94K | 534.22K | 598.59K | 394.31K | 455.95K | 516.58K | 72.23K | 137.23K |
| Property, Plant & Equipment | 209.26B | 275.86K | 340.98K | 404.66K | 466.94K | 266.95K | 331.33K | 394.31K | 455.95K | 516.58K | 72.23K | 137.23K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 267.26K | 267.26K | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 66.48T | 72.06M | 77.8M | 84.96M | 93.2M | 104.61M | 117.32M | 126.04M | 141.3M | 148.33M | 147.28M | 155.62M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 71336956.19% | -31.11% | -33.68% | -32.59% | -34.04% | -29.48% | -20.34% | -19% | -16% | -18.18% | -22.36% | -22.58% |
| Total Current Liabilities | 24.33T | 27.81M | 28.48M | 29.53M | 14.29M | 18.6M | 17.15M | 27.59M | 21.68M | 22.26M | 21.62M | 15.61M |
| Accounts Payable | 141.36B | 158.46K | 13.42K | 1.46M | 346.15K | 180.45K | 186.92K | 254.43K | 280.3K | 1.34M | 247.19K | 270.82K |
| Days Payables Outstanding | 1000K | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 15.51T | 15.25M | 15.47M | 15.15M | 0 | 31.37K | 279.96K | 15.24M | 15.2M | 15.15M | 13.46M | 5.89M |
| Deferred Revenue (Current) | 6T | 6M | 6M | 6M | 6M | 6M | 6M | 6M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.67T | 4.27M | 7.01M | 3.16M | 4.26M | 4.33M | 4.28M | 2.57M | 2.91M | 3.09M | 5.24M | 5.8M |
| Current Ratio | 2.72x | 2.58x | 2.72x | 2.86x | 6.49x | 5.59x | 6.80x | 4.55x | 6.50x | 6.64x | 6.81x | 9.96x |
| Quick Ratio | 2.72x | 2.58x | 2.72x | 2.86x | 6.49x | 5.59x | 6.80x | 4.55x | 6.50x | 6.64x | 6.81x | 9.96x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 72.54K | 143.45K | 15.31M | 15M | 15.07M | 138.89K | 6.21M | 6.27M | 2.66M | 10.13M |
| Long-Term Debt | 0 | 0 | 72.54K | 0 | 15.1M | 15M | 15M | 0 | 0 | 0 | 2.66M | 10.13M |
| Capital Lease Obligations | 0 | 0 | 0 | 143.45K | 212.77K | 0 | 70.23K | 138.89K | 206.01K | 271.63K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 24.33T | 27.81M | 28.56M | 29.67M | 29.6M | 33.6M | 32.22M | 27.73M | 27.88M | 28.53M | 24.27M | 25.73M |
| Total Debt | 15.51T | 15.53M | 15.54M | 15.56M | 15.57M | 15.3M | 15.61M | 15.64M | 15.66M | 15.66M | 16.18M | 16.15M |
| Net Debt | -49.49T | -54.51M | -43.8M | -25.69M | -34.78M | -39.22M | -52.51M | -55.39M | -86.83M | -127.17M | -127.15M | -135.52M |
| Debt / Equity | 0.37x | 0.35x | 0.32x | 0.28x | 0.24x | 0.22x | 0.18x | 0.16x | 0.14x | 0.13x | 0.13x | 0.12x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -7.57x | -12.60x | -15.16x | -19.75x | -19.54x | -32.57x | -30.53x | -34.28x | -15.21x | -8.24x | -14.20x | -16.05x |
| Total Equity | 42.16T | 44.25M | 49.24M | 55.29M | 63.6M | 71M | 85.1M | 98.31M | 113.42M | 119.8M | 123.01M | 129.88M |
| Equity Growth % | 66285647.24% | -37.68% | -42.13% | -43.76% | -43.93% | -40.73% | -30.82% | -24.31% | -17.36% | -20.67% | -24.16% | -25.37% |
| Book Value per Share | 698897.40 | 0.74 | 0.82 | 0.92 | 1.06 | 1.19 | 1.43 | 1.65 | 1.91 | 2.02 | 2.09 | 2.21 |
| Total Shareholders' Equity | 42.16T | 44.25M | 49.24M | 55.29M | 63.6M | 71M | 85.1M | 98.31M | 113.42M | 119.8M | 123.01M | 129.88M |
| Common Stock | 60.32B | 60.16K | 60.16K | 60.05K | 60.05K | 59.65K | 59.55K | 59.41K | 59.41K | 59.2K | 59.19K | 58.8K |
| Retained Earnings | -487.41T | -483.96M | -477.5M | -469.81M | -460.04M | -450.11M | -434.3M | -419.19M | -402.34M | -394.26M | -389.51M | -381.32M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 815 | -10.99K | 1.6K | 37.44K | 66.54K | -9.66K | -3.03K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |